US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 108.230
  • +6.090+5.96%
Close Nov 21 16:00 ET
  • 107.230
  • -1.000-0.92%
Pre 04:38 ET
25.95BMarket Cap-53262P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
6.10%16.71B
11.17%17.3B
25.31%15.67B
17.67%16.55B
17.67%16.55B
17.28%15.75B
66.66%15.56B
102.79%12.5B
578.04%14.06B
578.04%14.06B
-Cash and cash equivalents
-28.68%9.62B
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
-15.94%11.66B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
719.70%13.88B
-Short-term investments
214.41%7.08B
397.52%6.92B
1,768.69%6.69B
2,479.36%4.89B
2,479.36%4.89B
46,843.75%2.25B
1,390,600.00%1.39B
39,677.78%358M
-50.37%189.4M
-50.37%189.4M
Receivables
-47.87%1.2B
-90.44%286.5M
-72.45%1.93B
-67.26%2.34B
-67.26%2.34B
-68.56%2.3B
-71.15%3B
-44.95%6.99B
-42.29%7.15B
-42.29%7.15B
-Accounts receivable
-50.65%988M
-97.15%75.8M
-74.58%1.64B
-69.83%2.16B
-69.83%2.16B
-72.61%2B
-74.40%2.66B
-49.19%6.45B
-42.29%7.15B
-42.29%7.15B
-Taxes receivable
-27.41%210M
-37.64%206.8M
-48.69%273.3M
44,675.00%179.1M
44,675.00%179.1M
72,225.00%289.3M
82,800.00%331.6M
133,050.00%532.6M
0.00%400K
0.00%400K
-Other receivables
----
-33.90%3.9M
112.28%12.1M
--4.9M
--4.9M
--6.8M
--5.9M
--5.7M
----
----
Inventory
-27.09%303.1M
-24.24%340.1M
-18.56%345.4M
-18.63%357.7M
-18.63%357.7M
41.01%415.7M
22.08%448.9M
-7.66%424.1M
-12.52%439.6M
-12.52%439.6M
Other current assets
-3.63%275.8M
69.24%359.3M
96.73%337M
3.31%280.9M
3.31%280.9M
75.91%286.2M
355.58%212.3M
163.94%171.3M
139.77%271.9M
139.77%271.9M
Total current assets
-1.40%18.49B
-4.85%18.28B
-9.02%18.27B
-10.92%19.53B
-10.92%19.53B
-11.85%18.75B
-4.92%19.21B
3.19%20.09B
45.45%21.92B
45.45%21.92B
Non current assets
Net PPE
25.22%1.16B
25.84%1.13B
21.63%1.03B
18.33%971.6M
18.33%971.6M
21.75%925.9M
34.62%894M
52.20%847.6M
57.78%821.1M
57.78%821.1M
-Gross PPE
25.22%1.16B
25.84%1.13B
21.63%1.03B
26.24%1.18B
26.24%1.18B
21.75%925.9M
34.62%894M
52.20%847.6M
57.65%937.4M
57.65%937.4M
-Accumulated depreciation
----
----
----
-82.12%-211.8M
-82.12%-211.8M
----
----
----
-56.74%-116.3M
-56.74%-116.3M
Goodwill and other intangible assets
21.03%1.25B
146.25%1.23B
214.42%1.19B
431.00%1.17B
431.00%1.17B
355.84%1.03B
126.47%501.4M
75.28%378.6M
8.55%219.7M
8.55%219.7M
-Goodwill
2.30%374M
--372.4M
--368.7M
492.32%362.5M
492.32%362.5M
--365.6M
----
----
5.88%61.2M
5.88%61.2M
-Other intangible assets
31.31%873.9M
--862.3M
--821.7M
407.32%804.1M
407.32%804.1M
--665.5M
----
----
9.61%158.5M
9.61%158.5M
Investments and advances
3.06%1.33B
0.86%1.39B
207.12%1.59B
1,366.46%1.18B
1,366.46%1.18B
2,348.30%1.29B
2,568.54%1.37B
967.77%516.8M
276.53%80.2M
276.53%80.2M
Non current deferred assets
-56.42%90.7M
-57.29%102.3M
-62.93%91M
-64.59%81.3M
-64.59%81.3M
-40.75%208.1M
2,447.87%239.5M
2,053.51%245.5M
--229.6M
--229.6M
Other non current assets
28,166.67%84.8M
4,228.00%108.2M
1,790.91%83.2M
1,183.08%83.4M
1,183.08%83.4M
-72.73%300K
177.78%2.5M
450.00%4.4M
-54.86%6.5M
-54.86%6.5M
Total non current assets
13.21%3.92B
31.36%3.96B
99.84%3.98B
156.36%3.48B
156.36%3.48B
148.46%3.46B
217.92%3.01B
139.10%1.99B
78.92%1.36B
78.92%1.36B
Total assets
0.87%22.4B
0.06%22.24B
0.81%22.26B
-1.17%23.01B
-1.17%23.01B
-2.00%22.21B
5.06%22.23B
8.77%22.08B
47.05%23.28B
47.05%23.28B
Liabilities
Current liabilities
Payables
46.66%1.13B
59.12%1.25B
17.22%652M
9.94%879.5M
9.94%879.5M
-54.40%767.9M
-54.15%783.5M
-67.99%556.2M
-53.73%800M
-53.73%800M
-accounts payable
242.43%762.6M
285.61%881.5M
899.33%298.8M
73.44%354M
73.44%354M
-24.89%222.7M
-21.47%228.6M
-75.83%29.9M
27.56%204.1M
27.56%204.1M
-Total tax payable
-33.31%363.6M
-34.19%365.2M
-32.89%353.2M
-11.81%525.5M
-11.81%525.5M
-60.71%545.2M
-60.86%554.9M
-67.39%526.3M
-62.02%595.9M
-62.02%595.9M
Current provisions
130.03%731.5M
-2.91%363.9M
-38.34%247M
-31.23%269.3M
-31.23%269.3M
-58.60%318M
-37.14%374.8M
-6.66%400.6M
95.60%391.6M
95.60%391.6M
Current debt and capital lease obligation
-6.50%37.4M
-8.55%35.3M
-16.31%31.3M
-21.94%28.1M
-21.94%28.1M
8.11%40M
19.50%38.6M
22.22%37.4M
-72.29%36M
-72.29%36M
-Current debt
-6.50%37.4M
-8.55%35.3M
-16.31%31.3M
-21.94%28.1M
-21.94%28.1M
8.11%40M
19.50%38.6M
22.22%37.4M
-72.29%36M
-72.29%36M
Current deferred liabilities
41.23%236M
135.74%474.3M
1,542.27%361.3M
358.24%353.3M
358.24%353.3M
-75.31%167.1M
-69.48%201.2M
-88.72%22M
-58.57%77.1M
-58.57%77.1M
Other current liabilities
-23.88%391.4M
-27.37%305.7M
-41.20%314.4M
-67.17%540.3M
-67.17%540.3M
-35.05%514.2M
-54.59%420.9M
-63.43%534.7M
33.11%1.65B
33.11%1.65B
Current liabilities
39.58%2.52B
33.36%2.43B
3.55%1.61B
-29.83%2.07B
-29.83%2.07B
-54.34%1.81B
-53.64%1.82B
-59.76%1.55B
-15.25%2.95B
-15.25%2.95B
Non current liabilities
Long term provisions
-1.16%8.5M
4.65%9M
2.33%8.8M
2.33%8.8M
2.33%8.8M
17.81%8.6M
17.81%8.6M
-96.42%8.6M
-95.35%8.6M
-95.35%8.6M
Long term debt and capital lease obligation
27.42%206.3M
31.24%219.3M
18.91%205M
8.40%191M
8.40%191M
-31.69%161.9M
-19.12%167.1M
10.94%172.4M
2.68%176.2M
2.68%176.2M
-Long term debt
27.42%206.3M
31.24%219.3M
18.91%205M
8.40%191M
8.40%191M
-31.69%161.9M
-19.12%167.1M
10.94%172.4M
2.68%176.2M
2.68%176.2M
Non current deferred liabilities
33.30%414.7M
27.66%391.4M
722.40%418.6M
702.56%438.2M
702.56%438.2M
411.68%311.1M
96.16%306.6M
-56.61%50.9M
-27.87%54.6M
-27.87%54.6M
Other non current liabilities
161.05%134.7M
574.16%120M
149.75%50.2M
124.68%51.9M
124.68%51.9M
119.57%51.6M
-25.83%17.8M
16.18%20.1M
22.22%23.1M
22.22%23.1M
Total non current liabilities
43.32%764.2M
47.91%739.7M
159.74%682.6M
152.80%689.9M
152.80%689.9M
58.41%533.2M
24.71%500.1M
-50.82%262.8M
-40.09%272.9M
-40.09%272.9M
Total liabilities
40.43%3.29B
36.50%3.17B
26.18%2.29B
-14.37%2.76B
-14.37%2.76B
-45.50%2.34B
-46.38%2.32B
-58.68%1.81B
-18.13%3.22B
-18.13%3.22B
Shareholders'equity
Share capital
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.73%248.6M
0.93%248.6M
0.93%248.6M
-common stock
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.00%248.6M
0.73%248.6M
0.93%248.6M
0.93%248.6M
Retained earnings
-2.42%18.84B
-2.63%18.64B
0.58%19.45B
4.94%19.76B
4.94%19.76B
16.62%19.31B
29.62%19.14B
42.36%19.34B
90.56%18.83B
90.56%18.83B
Paid-in capital
11.77%1.37B
-13.49%1.23B
-20.61%1.23B
-32.75%1.23B
-32.75%1.23B
16.95%1.23B
-15.71%1.42B
-21.68%1.55B
9.19%1.83B
9.19%1.83B
Less: Treasury stock
-18.52%8.8M
22.73%10.8M
42.11%10.8M
103.77%10.8M
103.77%10.8M
4.85%10.8M
49.15%8.8M
100.00%7.6M
39.47%5.3M
39.47%5.3M
Gains losses not affecting retained earnings
-47.75%-1.34B
-15.04%-1.04B
-10.24%-946.7M
-15.99%-984.6M
-15.99%-984.6M
-272.90%-904.8M
-800.70%-902.5M
-882.86%-858.8M
-1,004.05%-848.9M
-1,004.05%-848.9M
Total stockholders'equity
-3.79%19.11B
-4.19%19.07B
-1.47%19.97B
0.95%20.25B
0.95%20.25B
8.17%19.87B
18.27%19.91B
27.37%20.27B
68.62%20.06B
68.62%20.06B
Total equity
-3.79%19.11B
-4.19%19.07B
-1.47%19.97B
0.95%20.25B
0.95%20.25B
8.17%19.87B
18.27%19.91B
27.37%20.27B
68.62%20.06B
68.62%20.06B
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 6.10%16.71B11.17%17.3B25.31%15.67B17.67%16.55B17.67%16.55B17.28%15.75B66.66%15.56B102.79%12.5B578.04%14.06B578.04%14.06B
-Cash and cash equivalents -28.68%9.62B-26.75%10.38B-26.08%8.98B-15.94%11.66B-15.94%11.66B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B719.70%13.88B
-Short-term investments 214.41%7.08B397.52%6.92B1,768.69%6.69B2,479.36%4.89B2,479.36%4.89B46,843.75%2.25B1,390,600.00%1.39B39,677.78%358M-50.37%189.4M-50.37%189.4M
Receivables -47.87%1.2B-90.44%286.5M-72.45%1.93B-67.26%2.34B-67.26%2.34B-68.56%2.3B-71.15%3B-44.95%6.99B-42.29%7.15B-42.29%7.15B
-Accounts receivable -50.65%988M-97.15%75.8M-74.58%1.64B-69.83%2.16B-69.83%2.16B-72.61%2B-74.40%2.66B-49.19%6.45B-42.29%7.15B-42.29%7.15B
-Taxes receivable -27.41%210M-37.64%206.8M-48.69%273.3M44,675.00%179.1M44,675.00%179.1M72,225.00%289.3M82,800.00%331.6M133,050.00%532.6M0.00%400K0.00%400K
-Other receivables -----33.90%3.9M112.28%12.1M--4.9M--4.9M--6.8M--5.9M--5.7M--------
Inventory -27.09%303.1M-24.24%340.1M-18.56%345.4M-18.63%357.7M-18.63%357.7M41.01%415.7M22.08%448.9M-7.66%424.1M-12.52%439.6M-12.52%439.6M
Other current assets -3.63%275.8M69.24%359.3M96.73%337M3.31%280.9M3.31%280.9M75.91%286.2M355.58%212.3M163.94%171.3M139.77%271.9M139.77%271.9M
Total current assets -1.40%18.49B-4.85%18.28B-9.02%18.27B-10.92%19.53B-10.92%19.53B-11.85%18.75B-4.92%19.21B3.19%20.09B45.45%21.92B45.45%21.92B
Non current assets
Net PPE 25.22%1.16B25.84%1.13B21.63%1.03B18.33%971.6M18.33%971.6M21.75%925.9M34.62%894M52.20%847.6M57.78%821.1M57.78%821.1M
-Gross PPE 25.22%1.16B25.84%1.13B21.63%1.03B26.24%1.18B26.24%1.18B21.75%925.9M34.62%894M52.20%847.6M57.65%937.4M57.65%937.4M
-Accumulated depreciation -------------82.12%-211.8M-82.12%-211.8M-------------56.74%-116.3M-56.74%-116.3M
Goodwill and other intangible assets 21.03%1.25B146.25%1.23B214.42%1.19B431.00%1.17B431.00%1.17B355.84%1.03B126.47%501.4M75.28%378.6M8.55%219.7M8.55%219.7M
-Goodwill 2.30%374M--372.4M--368.7M492.32%362.5M492.32%362.5M--365.6M--------5.88%61.2M5.88%61.2M
-Other intangible assets 31.31%873.9M--862.3M--821.7M407.32%804.1M407.32%804.1M--665.5M--------9.61%158.5M9.61%158.5M
Investments and advances 3.06%1.33B0.86%1.39B207.12%1.59B1,366.46%1.18B1,366.46%1.18B2,348.30%1.29B2,568.54%1.37B967.77%516.8M276.53%80.2M276.53%80.2M
Non current deferred assets -56.42%90.7M-57.29%102.3M-62.93%91M-64.59%81.3M-64.59%81.3M-40.75%208.1M2,447.87%239.5M2,053.51%245.5M--229.6M--229.6M
Other non current assets 28,166.67%84.8M4,228.00%108.2M1,790.91%83.2M1,183.08%83.4M1,183.08%83.4M-72.73%300K177.78%2.5M450.00%4.4M-54.86%6.5M-54.86%6.5M
Total non current assets 13.21%3.92B31.36%3.96B99.84%3.98B156.36%3.48B156.36%3.48B148.46%3.46B217.92%3.01B139.10%1.99B78.92%1.36B78.92%1.36B
Total assets 0.87%22.4B0.06%22.24B0.81%22.26B-1.17%23.01B-1.17%23.01B-2.00%22.21B5.06%22.23B8.77%22.08B47.05%23.28B47.05%23.28B
Liabilities
Current liabilities
Payables 46.66%1.13B59.12%1.25B17.22%652M9.94%879.5M9.94%879.5M-54.40%767.9M-54.15%783.5M-67.99%556.2M-53.73%800M-53.73%800M
-accounts payable 242.43%762.6M285.61%881.5M899.33%298.8M73.44%354M73.44%354M-24.89%222.7M-21.47%228.6M-75.83%29.9M27.56%204.1M27.56%204.1M
-Total tax payable -33.31%363.6M-34.19%365.2M-32.89%353.2M-11.81%525.5M-11.81%525.5M-60.71%545.2M-60.86%554.9M-67.39%526.3M-62.02%595.9M-62.02%595.9M
Current provisions 130.03%731.5M-2.91%363.9M-38.34%247M-31.23%269.3M-31.23%269.3M-58.60%318M-37.14%374.8M-6.66%400.6M95.60%391.6M95.60%391.6M
Current debt and capital lease obligation -6.50%37.4M-8.55%35.3M-16.31%31.3M-21.94%28.1M-21.94%28.1M8.11%40M19.50%38.6M22.22%37.4M-72.29%36M-72.29%36M
-Current debt -6.50%37.4M-8.55%35.3M-16.31%31.3M-21.94%28.1M-21.94%28.1M8.11%40M19.50%38.6M22.22%37.4M-72.29%36M-72.29%36M
Current deferred liabilities 41.23%236M135.74%474.3M1,542.27%361.3M358.24%353.3M358.24%353.3M-75.31%167.1M-69.48%201.2M-88.72%22M-58.57%77.1M-58.57%77.1M
Other current liabilities -23.88%391.4M-27.37%305.7M-41.20%314.4M-67.17%540.3M-67.17%540.3M-35.05%514.2M-54.59%420.9M-63.43%534.7M33.11%1.65B33.11%1.65B
Current liabilities 39.58%2.52B33.36%2.43B3.55%1.61B-29.83%2.07B-29.83%2.07B-54.34%1.81B-53.64%1.82B-59.76%1.55B-15.25%2.95B-15.25%2.95B
Non current liabilities
Long term provisions -1.16%8.5M4.65%9M2.33%8.8M2.33%8.8M2.33%8.8M17.81%8.6M17.81%8.6M-96.42%8.6M-95.35%8.6M-95.35%8.6M
Long term debt and capital lease obligation 27.42%206.3M31.24%219.3M18.91%205M8.40%191M8.40%191M-31.69%161.9M-19.12%167.1M10.94%172.4M2.68%176.2M2.68%176.2M
-Long term debt 27.42%206.3M31.24%219.3M18.91%205M8.40%191M8.40%191M-31.69%161.9M-19.12%167.1M10.94%172.4M2.68%176.2M2.68%176.2M
Non current deferred liabilities 33.30%414.7M27.66%391.4M722.40%418.6M702.56%438.2M702.56%438.2M411.68%311.1M96.16%306.6M-56.61%50.9M-27.87%54.6M-27.87%54.6M
Other non current liabilities 161.05%134.7M574.16%120M149.75%50.2M124.68%51.9M124.68%51.9M119.57%51.6M-25.83%17.8M16.18%20.1M22.22%23.1M22.22%23.1M
Total non current liabilities 43.32%764.2M47.91%739.7M159.74%682.6M152.80%689.9M152.80%689.9M58.41%533.2M24.71%500.1M-50.82%262.8M-40.09%272.9M-40.09%272.9M
Total liabilities 40.43%3.29B36.50%3.17B26.18%2.29B-14.37%2.76B-14.37%2.76B-45.50%2.34B-46.38%2.32B-58.68%1.81B-18.13%3.22B-18.13%3.22B
Shareholders'equity
Share capital 0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.73%248.6M0.93%248.6M0.93%248.6M
-common stock 0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.00%248.6M0.73%248.6M0.93%248.6M0.93%248.6M
Retained earnings -2.42%18.84B-2.63%18.64B0.58%19.45B4.94%19.76B4.94%19.76B16.62%19.31B29.62%19.14B42.36%19.34B90.56%18.83B90.56%18.83B
Paid-in capital 11.77%1.37B-13.49%1.23B-20.61%1.23B-32.75%1.23B-32.75%1.23B16.95%1.23B-15.71%1.42B-21.68%1.55B9.19%1.83B9.19%1.83B
Less: Treasury stock -18.52%8.8M22.73%10.8M42.11%10.8M103.77%10.8M103.77%10.8M4.85%10.8M49.15%8.8M100.00%7.6M39.47%5.3M39.47%5.3M
Gains losses not affecting retained earnings -47.75%-1.34B-15.04%-1.04B-10.24%-946.7M-15.99%-984.6M-15.99%-984.6M-272.90%-904.8M-800.70%-902.5M-882.86%-858.8M-1,004.05%-848.9M-1,004.05%-848.9M
Total stockholders'equity -3.79%19.11B-4.19%19.07B-1.47%19.97B0.95%20.25B0.95%20.25B8.17%19.87B18.27%19.91B27.37%20.27B68.62%20.06B68.62%20.06B
Total equity -3.79%19.11B-4.19%19.07B-1.47%19.97B0.95%20.25B0.95%20.25B8.17%19.87B18.27%19.91B27.37%20.27B68.62%20.06B68.62%20.06B
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+1.23%